Drug Price Trends for FLUTICASONE-VILANTEROL

Average Pharmacy Cost for FLUTICASONE-VILANTEROL

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
FLUTICASONE-VILANTEROL 200-25	66993-0136-97	3.70584	EACH	2024-12-18
FLUTICASONE-VILANTEROL 100-25	66993-0135-97	3.75244	EACH	2024-12-18
FLUTICASONE-VILANTEROL 200-25	66993-0136-97	3.62107	EACH	2024-11-20
FLUTICASONE-VILANTEROL 100-25	66993-0135-97	3.63823	EACH	2024-11-20
FLUTICASONE-VILANTEROL 200-25	66993-0136-97	3.72974	EACH	2024-10-23

Market Analysis and Price Projections for Fluticasone-Vilanterol

Market Overview

Fluticasone-vilanterol, a combination of an inhaled corticosteroid (fluticasone) and a long-acting beta-agonist (vilanterol), is widely used for the treatment of asthma and chronic obstructive pulmonary disease (COPD). This drug is marketed under brand names such as Breo Ellipta.

Market Size and Growth

The global inhaled corticosteroids market, which includes fluticasone-vilanterol, is expected to grow significantly over the forecast period. According to Data Bridge Market Research, the inhaled corticosteroids market was valued at USD 840 million in 2021 and is projected to reach USD 1,222.28 million by 2029, growing at a CAGR of 4.80% from 2022 to 2029[1].

Key Drivers

Several factors are driving the growth of the fluticasone-vilanterol market:

Surging Prevalence of Asthma and COPD

The increasing prevalence of respiratory diseases such as asthma and COPD is a major driver. These conditions are becoming more common, leading to higher demand for effective treatments like fluticasone-vilanterol[1].

Increasing Investment in Healthcare Infrastructure

Rising healthcare expenditure and improvements in healthcare infrastructure are also contributing to the market's growth. Better healthcare facilities and increased access to medications are crucial for the adoption of fluticasone-vilanterol[1].

Rising Geriatric Population

The growing geriatric population is more prone to chronic respiratory ailments, which further boosts the demand for inhaled corticosteroids like fluticasone-vilanterol. By 2050, the number of elderly people is expected to increase to 1.5 billion, significantly impacting the market[1].

Market Segmentation

The market for fluticasone-vilanterol can be segmented based on several criteria:

Indication

• Asthma
• Chronic Obstructive Pulmonary Disease (COPD)
• Others

Type

• Fluticasone-vilanterol is a specific combination, but the broader category includes other inhaled corticosteroids like beclomethasone dipropionate, budesonide, and mometasone[1].

Dosage Form

• Aerosol Liquid
• Aerosol Powder
• Powder
• Suspension

End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others[1].

Price Analysis

The cost of fluticasone-vilanterol can vary based on the dosage and the pharmacy.

Current Pricing

• For a supply of 60 powder inhalers of fluticasone-vilanterol (100 mcg-25 mcg/inh), the cost is approximately $381.44. For a smaller supply of 28 powder inhalers, the cost is around $174.70[2][5].

Discounts and Assistance Programs

• Patients can benefit from discount cards, coupons, and copay cards, which can reduce the cost significantly. For example, the Drugs.com Discount Card can save up to 80% on prescription medicines[2][5].

Sales Forecast

The sales forecast for fluticasone-vilanterol is positive, driven by the growing demand for respiratory treatments.

Sales Trends

• The sales data from previous years indicate a steady growth trend. For instance, the sales forecast report by Research and Markets provides insights into sales trends and forecasts until 2021, which can be extrapolated to understand future growth[3].

Geographic Distribution

• The market is geographically diverse, with North America and Europe accounting for the largest shares due to high incidence rates of asthma and COPD. The Asia Pacific region is expected to grow at the fastest rate due to a large target population and government support for healthcare[4].

Challenges and Restraints

Despite the positive outlook, there are several challenges that could impact the market:

Expiration of Patented Drugs

• The introduction of generic versions of fluticasone-vilanterol can reduce the market share of branded products, affecting revenue[1].

High Cost and Side Effects

• The high cost associated with inhaled corticosteroids and potential side effects such as oral thrush, cough, hoarseness, and sore throat can act as restraints to market growth[1].

Key Takeaways

• Growing Demand: The increasing prevalence of asthma and COPD is driving the demand for fluticasone-vilanterol.
• Market Growth: The inhaled corticosteroids market, including fluticasone-vilanterol, is expected to grow at a CAGR of 4.80% from 2022 to 2029.
• Pricing: The cost of fluticasone-vilanterol varies, but discounts and assistance programs can significantly reduce the cost.
• Challenges: The market faces challenges from generic versions, high costs, and potential side effects.

FAQs

1. What is fluticasone-vilanterol used for? Fluticasone-vilanterol is used for the treatment of asthma and chronic obstructive pulmonary disease (COPD).

2. How much does fluticasone-vilanterol cost? The cost of fluticasone-vilanterol can range from approximately $174.70 for a supply of 28 powder inhalers to $381.44 for a supply of 60 powder inhalers, depending on the pharmacy and dosage.

3. Are there any discounts available for fluticasone-vilanterol? Yes, patients can benefit from discount cards, coupons, and copay cards, which can reduce the cost significantly.

4. What are the main drivers of the fluticasone-vilanterol market? The main drivers include the surging prevalence of asthma and COPD, increasing investment in healthcare infrastructure, and the rising geriatric population.

5. What are the potential challenges for the fluticasone-vilanterol market? The potential challenges include the expiration of patented drugs, high costs associated with the medication, and side effects linked with inhaled corticosteroids.

Sources

1. Data Bridge Market Research - Global Inhaled Corticosteroids Market[1].
2. Drugs.com - Fluticasone/vilanterol Prices, Coupons, Copay Cards & Patient Assistance[2].
3. Business Wire - Fluticasone Furoate / Vilanterol Sales, Price Analysis, & Sales Forecast[3].
4. iHealthcareAnalyst - Global Inhalation and Nasal Spray Drugs Market[4].
5. Drugs.com - Breo Ellipta Prices, Coupons, Copay Cards & Patient Assistance[5].